February 4, 2020
DILIsym Services, a Simulations Plus company, in partnership with a large pharmaceutical company, is developing a QSP model focused on heart failure. QSP Modeling Project Targeted at Prevention of Heart Failure DILIsym Services Inc. (DSS), a Simulations Plus company (Nasdaq: SLP) and a leading provider of simulation and modeling software for pharmaceutical efficacy and safety, [...]
February 4, 2020
ST. LOUIS, MO —Biotech company Adarza BioSystems announced today that it has raised $25 million in a Series D round co-led by 3×5 Partners, based in Portland, Ore., and St. Louis-based Lightchain Capital, LLC, the family office of Scottrade founder Rodger Riney. Adarza plans to use the funds to support full commercialization of ZIVA, its [...]
Applied Photophysics board appoints Tim Flanagan as CEO
February 4, 2020
Applied Photophysics Limited, a world leader in biophysical characterization of biomolecules, has today announced that its Board of Directors has appointed Tim Flanagan as Chief Executive Officer and member of the Board of Directors effective immediately. Additionally, Marc Neglia has been appointed President of Applied Photophysics Inc. to lead operations in the Americas and will [...]
HELIX SELECTS SWIFT BIOSCIENCES TO POWER EXOME+™ ASSAY WITH SWIFT 2S™ TURBO DNA LIBRARY SYSTEM
February 4, 2020
ANN ARBOR, Mich. –Swift Biosciences, Inc (“Swift”) and Helix OpCo, LLC (“Helix”) today announced a Partnership Agreement to leverage Swift’s 2S Turbo DNA library preparation for Helix’s Exome+™ assay. Helix, a population genomics company, uses the Exome+™ assay to power population health programs focused on accelerating the integration of genomics into clinical care and facilitating [...]
The Native Antigen Company Introduces Antigen and Antibody Conjugation Kits
February 4, 2020
Highly scalable kits enable researchers to prepare liquid-stable antigen and antibody conjugates with a wide range of labels including enzymes, fluorochromes, and biotin Oxford, UK: The Native Antigen Company, one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the commercial release of its [...]
February 4, 2020
TORONTO -- BenchSci, which uses machine learning to identify and resolve preclinical research inefficiencies in drug discovery, announced today it has raised $22 million in Series B financing, launched its new AI-Assisted Reagent Selection product, and expanded its contract with Novartis in a market worth more than $10.2 billion per year in life science R&D cost-saving opportunities. F-Prime [...]
Crystal Diagnostics Granted New Patent for Rapid Detection of Foodborne Pathogens
February 4, 2020
A fully automated, high throughput rapid pathogen detection platform is scheduled for market release in April 2020 Crystal Diagnostics (CDx) announced today that the US Patent and Trademark Office (USPTO) issued the company a second patent related to proprietary liquid crystal technology for rapid and accurate detection of foodborne pathogens. The Notice of Allowance complements [...]
Shoreline Biome announces new Asian distribution partnership
February 4, 2020
Microbiome products now available in China, Hong Kong, and Macau FARMINGTON, Conn.— Shoreline Biome, a microbiome research company that develops tools for characterizing microbiome populations down to the strain level, has announced a new distribution partnership in Asia. The distribution partner, Gene Company Limited, will sell Shoreline Biome’s microbiome kits and other products to companies [...]
February 4, 2020
MOLNDAL, SWEDEN and VICTORIA, BC, CANADA – Cellectricon, a collaborative services provider dedicated to advancing drug discovery and research in the areas of chronic pain and neurodegenerative diseases announces a collaboration with StressMarq Biosciences. As a supplier of life science reagents such as primary antibodies, antibody conjugates, proteins, immunoassay kits and small molecules, Stressmarq Biosciences will [...]
February 4, 2020
Novasep, a leading supplier of services and technologies for the life sciences industry, announces Enzene Biosciences (India) has chosen BioSC® Pilot for purification of biopharmaceuticals to operate in its Pune plant. BioSC® Pilot is dedicated to the purification of biomolecules such as monoclonal antibodies (mAbs), from early pilot phase to small commercial production. It fits particularly [...]
